MyFinsight
Home
Blog
About
Proceeds from maturities
of short-term...
$119,091K
(-58.71%↓ Y/Y)
Proceeds from exercise of
share options
$1,213K
(20.34%↑ Y/Y)
Proceeds from issuance of
ordinary shares under...
$872K
(83.97%↑ Y/Y)
Purchases of property and
equipment
-$42K
(-107.69%↓ Y/Y)
Net cash (used in)
provided by investing...
$74,500K
(-10.21%↓ Y/Y)
Net cash provided by
financing activities
$2,085K
(57.24%↑ Y/Y)
Canceled cashflow
$44,633K
Net change in cash
and cash...
-$43,530K
(-93.59%↓ Y/Y)
Canceled cashflow
$76,585K
Share-based compensation
expense
$12,634K
(-5.91%↓ Y/Y)
Accrued expenses and
other current...
$5,513K
(111.15%↑ Y/Y)
Accounts payable
$3,309K
(242.55%↑ Y/Y)
Prepaid expenses and
other current assets
-$2,724K
(-153.32%↓ Y/Y)
Non-cash lease expense
$745K
(-23.35%↓ Y/Y)
Depreciation expense
$551K
(-2.48%↓ Y/Y)
Other non-current
liabilities
$144K
Accretion of asset
retirement obligation
$19K
Purchases of short-term
investments
$44,633K
(-78.22%↓ Y/Y)
Net cash used in
operating activities
-$120,115K
(-12.48%↓ Y/Y)
Canceled cashflow
$25,639K
Net loss
-$106,159K
(2.15%↑ Y/Y)
Other non-current
assets
$35,440K
(3133.58%↑ Y/Y)
Accretion of net
investment discounts
$3,392K
(-64.43%↓ Y/Y)
Operating lease
liabilities
-$763K
(30.13%↑ Y/Y)
Back
Back
Cash Flow
Structure Therapeutics Inc. (GPCR)
Structure Therapeutics Inc. (GPCR)
source: myfinsight.com